Manel Armengol Selected Research

Manel Armengol Research Topics

Disease

9	Neoplasms (Cancer) 01/2018 - 12/2002
5	Colorectal Neoplasms (Colorectal Cancer) 01/2012 - 12/2002
4	Rectal Neoplasms (Rectal Cancer) 12/2008 - 12/2002
3	Obesity 09/2021 - 01/2012
3	Incisional Hernia 05/2013 - 11/2009
2	Weight Loss (Weight Reduction) 10/2021 - 01/2015
2	Hemorrhage 10/2021 - 01/2021
2	Hypoglycemia (Reactive Hypoglycemia) 10/2021 - 11/2019
2	Gastroesophageal Reflux (GERD) 10/2020 - 11/2019
2	Pheochromocytoma 01/2018 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 01/2012 - 11/2005
2	Rupture 06/2011 - 11/2009
2	Pathologic Complete Response 12/2008 - 02/2005
1	Wounds and Injuries (Trauma) 10/2021
1	Colitis 10/2021
1	Dyslipidemias (Dyslipidemia) 10/2021
1	Mesenteric Ischemia 10/2021
1	Anastomotic Leak 09/2021
1	COVID-19 03/2021
1	Surgical Wound Infection 01/2021
1	Heart Diseases (Heart Disease) 10/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Obstructive Sleep Apnea 10/2020
1	Joint Diseases (Joint Disease) 10/2020
1	Gastrointestinal Hemorrhage (Hematochezia) 01/2020
1	Hiatal Hernia 11/2019
1	Edema (Dropsy) 01/2018
1	Myocarditis (Carditis) 01/2018
1	Cardiogenic Shock 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Lymphatic Metastasis 06/2015
1	Papillary Carcinoma 06/2015
1	Thrombosis (Thrombus) 01/2015
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2015
1	Fistula 01/2015
1	Abdominal Aortic Aneurysm 01/2015
1	Aneurysm (Aneurysms) 01/2015
1	Cushing Syndrome 01/2014
1	Hyperaldosteronism (Conn Syndrome) 01/2014
1	Neoplasm Metastasis (Metastasis) 01/2006
1	Microsatellite Instability 06/2005
1	Aneuploidy (Aneuploid) 09/2003
1	Carcinoma (Carcinomatosis) 12/2002

Drug/Important Bio-Agent (IBA)

2	Indicators and Reagents (Reagents)IBA 01/2006 - 12/2002
2	Phosphotransferases (Kinase)IBA 11/2005 - 06/2005
2	ErbB Receptors (EGF Receptor)IBA 02/2005 - 12/2002
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2018
1	CatecholaminesIBA 01/2018
1	Keratin-19 (Keratin 19)IBA 06/2015
1	Nucleic AcidsIBA 06/2015
1	Messenger RNA (mRNA)IBA 06/2015
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2015
1	allogenic effect factor (AEF)IBA 01/2015
1	Small Interfering RNA (siRNA)IBA 12/2012
1	CarcinogensIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Myosin Type I (Myosin IA)IBA 01/2012
1	AgarIBA 01/2012
1	Caspase 3 (Caspase-3)IBA 06/2011
1	Biological ProductsIBA 06/2011
1	Biomarkers (Surrogate Marker)IBA 04/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2010
1	Biological FactorsIBA 11/2009
1	InterleukinsIBA 11/2009
1	Matrix Metalloproteinases (MMPs)IBA 11/2009
1	CytokinesIBA 11/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009
1	Tissue Inhibitor of Metalloproteinase-3IBA 11/2009
1	Leucovorin (Folinic Acid)FDA Link 12/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2006
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	MethyltransferasesIBA 11/2005
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2005
1	Decitabine FDA Link 11/2005
1	gamma Catenin (Plakoglobin)IBA 09/2003

Therapy/Procedure

6	Bariatric Surgery 10/2021 - 08/2013
4	Gastrectomy 10/2021 - 01/2012
4	Radiotherapy 12/2008 - 12/2002
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 10/2021 - 11/2019
3	Laparotomy 05/2013 - 11/2009
2	Adrenalectomy 01/2018 - 01/2014
1	Prostheses and Implants (Prosthesis) 10/2021
1	Length of Stay 01/2021
1	Operative Time 01/2021
1	Continuous Positive Airway Pressure 10/2020
1	Nephrectomy 01/2020
1	Sutures (Suture) 01/2015
1	Operative Surgical Procedures 01/2014
1	Therapeutics 04/2010
1	Chemoradiotherapy 12/2008
1	Aftercare (After-Treatment) 11/2005